Manulife (Manufacturers Life Insurance)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.5M | Buy |
43,471
+6,444
| +17% | +$1.19M | 0.01% | 1005 |
|
|
2025
Q4 | $7.39M | Sell |
37,027
-160
| -0.4% | -$29K | 0.01% | 1028 |
|
|
2025
Q3 | $5.82M | Buy |
37,187
+16
| +0% | +$2.54K | ﹤0.01% | 1110 |
|
|
2025
Q2 | $5.64M | Sell |
37,171
-153,106
| -80% | -$20.4M | 0.01% | 1109 |
|
|
2025
Q1 | $28.6M | Sell |
190,277
-4,400
| -2% | -$738K | 0.03% | 505 |
|
|
2024
Q4 | $35.9M | Buy |
194,677
+57,412
| +42% | +$11.1M | 0.03% | 452 |
|
|
2024
Q3 | $27M | Sell |
137,265
-102,648
| -43% | -$21.3M | 0.02% | 538 |
|
|
2024
Q2 | $49.6M | Buy |
239,913
+101,732
| +74% | +$23.1M | 0.05% | 342 |
|
|
2024
Q1 | $37.4M | Sell |
138,181
-2,111
| -2% | -$504K | 0.03% | 426 |
|
|
2023
Q4 | $33.2M | Sell |
140,292
-29,563
| -17% | -$5.81M | 0.02% | 475 |
|
|
2023
Q3 | $33.3M | Buy |
169,855
+19,695
| +13% | +$4.04M | 0.02% | 438 |
|
|
2023
Q2 | $31.6M | Sell |
150,160
-15,231
| -9% | -$3.03M | 0.02% | 454 |
|
|
2023
Q1 | $33.4M | Sell |
165,391
-71,228
| -30% | -$16.1M | 0.02% | 444 |
|
|
2022
Q4 | $51.7M | Buy |
236,619
+15,842
| +7% | +$3.46M | 0.03% | 330 |
|
|
2022
Q3 | $43.3M | Buy |
220,777
+167,110
| +311% | +$36.1M | 0.03% | 358 |
|
|
2022
Q2 | $11.6M | Buy |
53,667
+17,793
| +50% | +$4.35M | 0.01% | 766 |
|
|
2022
Q1 | $10.2M | Sell |
35,874
-7,806
| -18% | -$2.41M | 0.01% | 897 |
|
|
2021
Q4 | $16.5K | Sell |
43,680
-3,707
| -8% | -$1.44M | 0.01% | 728 |
|
|
2021
Q3 | $19.6M | Sell |
47,387
-2,453
| -5% | -$1.02M | 0.02% | 659 |
|
|
2021
Q2 | $18.4M | Sell |
49,840
-5,997
| -11% | -$2M | 0.02% | 695 |
|
|
2021
Q1 | $16.2M | Sell |
55,837
-3,989
| -7% | -$1.11M | 0.01% | 743 |
|
|
2020
Q4 | $14.9M | Sell |
59,826
-5,278
| -8% | -$1.26M | 0.01% | 721 |
|
|
2020
Q3 | $14.7M | Sell |
65,104
-1,224
| -2% | -$254K | 0.02% | 642 |
|
|
2020
Q2 | $11.2M | Sell |
66,328
-3,622
| -5% | -$578K | 0.01% | 736 |
|
|
2020
Q1 | $8.83M | Buy |
69,950
+1,413
| +2% | +$212K | 0.01% | 765 |
|
|
2019
Q4 | $10.5M | Sell |
68,537
-3,904
| -5% | -$541K | 0.01% | 811 |
|
|
2019
Q3 | $9.61M | Sell |
72,441
-7,031
| -9% | -$943K | 0.01% | 841 |
|
|
2019
Q2 | $11.3M | Buy |
79,472
+853
| +1% | +$116K | 0.01% | 771 |
|
|
2019
Q1 | $11.4M | Sell |
78,619
-2,373
| -3% | -$312K | 0.01% | 789 |
|
|
2018
Q4 | $9.17M | Buy |
80,992
+1,392
| +2% | +$174K | 0.01% | 842 |
|
|
2018
Q3 | $10.7M | Buy |
79,600
+3,197
| +4% | +$395K | 0.01% | 843 |
|
|
2018
Q2 | $8.58M | Buy |
76,403
+541
| +0.7% | +$58.5K | 0.01% | 968 |
|
|
2018
Q1 | $8.1M | Sell |
75,862
-2,556
| -3% | -$276K | 0.01% | 997 |
|
|
2017
Q4 | $8.58M | Buy |
78,418
+8,669
| +12% | +$943K | 0.01% | 961 |
|
|
2017
Q3 | $7.53M | Sell |
69,749
-205
| -0.3% | -$21.1K | 0.01% | 966 |
|
|
2017
Q2 | $7.08M | Buy |
69,954
+1,505
| +2% | +$139K | 0.01% | 1001 |
|
|
2017
Q1 | $6.16M | Buy |
68,449
+3,969
| +6% | +$337K | 0.01% | 1053 |
|
|
2016
Q4 | $4.91M | Sell |
64,480
-371
| -0.6% | -$28.2K | 0.01% | 1099 |
|
|
2016
Q3 | $5.4M | Buy |
64,851
+1,116
| +2% | +$93.5K | 0.01% | 1017 |
|
|
2016
Q2 | $5.25M | Buy |
63,735
+2,047
| +3% | +$169K | 0.01% | 998 |
|
|
2016
Q1 | $4.65M | Buy |
61,688
+1,139
| +2% | +$84.3K | ﹤0.01% | 1074 |
|
|
2015
Q4 | $4.87K | Sell |
60,549
-412
| -0.7% | -$29.7K | ﹤0.01% | 1048 |
|
|
2015
Q3 | $3.87K | Sell |
60,961
-2,059
| -3% | -$148K | ﹤0.01% | 1146 |
|
|
2015
Q2 | $4.43K | Buy |
63,020
+1,955
| +3% | +$145K | 0.01% | 1110 |
|
|
2015
Q1 | $4.84K | Buy |
61,065
+996
| +2% | +$73.5K | 0.01% | 1049 |
|
|
2014
Q4 | $3.82K | Sell |
60,069
-1,446
| -2% | -$90.6K | 0.01% | 1098 |
|
|
2014
Q3 | $3.67K | Sell |
61,515
-1,430
| -2% | -$81.8K | 0.01% | 1130 |
|
|
2014
Q2 | $3.37M | Sell |
62,945
-6,840
| -10% | -$375K | 0.01% | 1193 |
|
|
2014
Q1 | $4.21K | Sell |
69,785
-1,222
| -2% | -$71.2K | 0.01% | 1091 |
|
|
2013
Q4 | $3.77K | Buy |
71,007
+6,974
| +11% | +$350K | 0.01% | 1135 |
|
|
2013
Q3 | $2.96K | Buy |
64,033
+587
| +0.9% | +$26.9K | ﹤0.01% | 1184 |
|
|
2013
Q2 | $2.6M | Buy |
+63,446
| New | +$2.72M | ﹤0.01% | 1160 |
|
Other funds holding CRL
VCM
VPM
Manulife (Manufacturers Life Insurance)'s CRL Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) increased its Charles River Laboratories (CRL) stake by 17% in Q1 2026, buying an estimated $1.19M and bringing the position to 43,471 shares worth $7.5M. The position accounts for 0.01% of the portfolio, ranked #1005.
Manulife (Manufacturers Life Insurance) first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $51.7M in Q4 2022. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 43,471 shares of Charles River Laboratories worth $7.5M as of Q1 2026.
- Manulife (Manufacturers Life Insurance) bought 6,444 Charles River Laboratories shares in Q1 2026, an estimated $1.19M.
- Charles River Laboratories made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1005 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
- Manulife (Manufacturers Life Insurance)'s Charles River Laboratories position peaked at $51.7M in Q4 2022.
- 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.